Published in
Royal Society of Chemistry, Dalton Transactions, 27(50), p. 9500-9511, 2021
DOI: 10.1039/d1dt01388b
Links
Tools
Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells
Journal article published in 2021 by
Sylwia Michlewska 
,
Marta Maroto,
Marcin Hołota,
Malgorzata Kubczak,
Natalia Sanz del Olmo,
Paula Ortega ,
Dzmitry Shcharbin ,
Francisco Javier de la Mata ,
Maria Bryszewska ,
Maksim Ionov
,
Marta Maroto,
Marcin Hołota,
Malgorzata Kubczak,
Natalia Sanz del Olmo,
Paula Ortega ,
Dzmitry Shcharbin ,
Francisco Javier de la Mata ,
Maria Bryszewska ,
Maksim Ionov
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
A new family of cationic ruthenium(ii) metallodendrimers of a carbosilane nature with the metal centre coordinated to 2-aminopyridine ligands have been synthesized and interacted with conventional anticancer drugs.